Southeast partnership to improve cancer outcomes and reduce disparities

3/3 Morehouse School of Medicine/Tuskegee University/University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Partnership

NIH-funded research University of Alabama at Birmingham · NIH-11164520

A collaboration between regional cancer centers and universities to build cancer research, training, and community outreach that aims to help people in underserved Southeastern communities affected by cancer.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Alabama at Birmingham NIH-funded
Lab location1 site (Birmingham, United States)
Project IDNIH-11164520 on NIH RePORTER

What this research studies

From a patient’s perspective, this partnership brings together hospitals and universities in Alabama and Georgia to offer more local research, education, and outreach about cancer. You may be invited to take part in pilot research projects, community programs, or biospecimen and data initiatives run by the partner institutions. The program supports cores in outreach, research education, administration, and evaluation plus shared resources in bioethics and biostatistics to strengthen studies and protect participants. It also trains and supports new cancer investigators so future studies and trials are more available and relevant to local communities.

Who could benefit from this research

Good fit: Ideal candidates are people with cancer or at elevated risk who live in the Southeast—particularly Alabama and nearby communities—and who are willing to take part in local research, outreach, or biospecimen programs.

Not a fit: People outside the partner region or those seeking an immediate new therapy should not expect direct or immediate treatment benefits from this infrastructure-focused partnership.

Why it matters

Potential benefit: If successful, the partnership could lead to better understanding of drivers of cancer outcomes in underserved populations and more locally available research and clinical opportunities.

How similar studies have performed: This application continues an established U54 partnership model that has previously helped expand research capacity and community engagement, though individual pilot projects vary in novelty and outcomes.

Where this research is happening

Birmingham, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Anti-Cancer Agents
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.